FR3839M - - Google Patents

Info

Publication number
FR3839M
FR3839M FR952517A FR952517A FR3839M FR 3839 M FR3839 M FR 3839M FR 952517 A FR952517 A FR 952517A FR 952517 A FR952517 A FR 952517A FR 3839 M FR3839 M FR 3839M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR952517A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of FR3839M publication Critical patent/FR3839M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR952517A 1962-08-06 1963-10-31 Expired FR3839M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US214854A US3255080A (en) 1962-08-06 1962-08-06 Live rabies virus vaccine and method for the production thereof

Publications (1)

Publication Number Publication Date
FR3839M true FR3839M (fr) 1966-01-17

Family

ID=22800666

Family Applications (1)

Application Number Title Priority Date Filing Date
FR952517A Expired FR3839M (fr) 1962-08-06 1963-10-31

Country Status (5)

Country Link
US (1) US3255080A (fr)
CH (1) CH455148A (fr)
DK (1) DK105426C (fr)
FR (1) FR3839M (fr)
GB (1) GB1001689A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453651A1 (fr) * 1979-04-10 1980-11-07 Schweiz Serum & Impfinst Procede de preparation d'un vaccin antirabique et vaccin obtenu suivant ce procede

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021302A (en) * 1966-02-18 1977-05-03 Burroughs Wellcome & Co., Inc. Cell cultures
US3674862A (en) * 1970-04-02 1972-07-04 Lilly Co Eli Live attenuated rabies virus vaccine and process therefor
GB1596653A (en) * 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2768114A (en) * 1953-08-21 1956-10-23 American Cyanamid Co Rabies vaccines and methods of preparing the same
US2965544A (en) * 1959-02-24 1960-12-20 American Cyanamid Co Tissue culture propagated canine distemper virus and vaccine thereof
US3080291A (en) * 1960-06-10 1963-03-05 Jensen Salsberg Lab Inc Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom
US3143470A (en) * 1961-04-24 1964-08-04 Parke Davis & Co Rabies virus propagation in embryonic cells maintained in a medium containing pancreatic digest of casein

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453651A1 (fr) * 1979-04-10 1980-11-07 Schweiz Serum & Impfinst Procede de preparation d'un vaccin antirabique et vaccin obtenu suivant ce procede

Also Published As

Publication number Publication date
GB1001689A (en) 1965-08-18
CH455148A (de) 1968-04-30
US3255080A (en) 1966-06-07
DK105426C (da) 1966-09-26

Similar Documents

Publication Publication Date Title
FR3055M (fr)
FR3839M (fr)
BE616548R (fr)
BE615849A (fr)
BE614403A (fr)
BE614532A (fr)
BE614432A (fr)
BE559145A (fr)
BE614380A (fr)
BE614159A (fr)
BE613862A (fr)
BE553896A (fr)
BE613335A (fr)
BE613319A (fr)
BE632079A (fr)
BE613298A (fr)
BE613190A (fr)
BE613108A (fr)
BE612926A (fr)
BE612847A (fr)
BE612464A (fr)
BE616785A (fr)
BE629478A (fr)
BE612311A (fr)
BE612190A (fr)